Retatrutide – The New Peptide Darling

Retatrutide is an investigational, multi-receptor agonist designed to target the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This novel mechanism of action allows it to simultaneously influence multiple metabolic pathways, making it an exciting compound for research into obesity, type 2 diabetes, and related metabolic disorders. By combining the effects of these three receptor pathways, retatrutide offers a promising approach to treating complex metabolic conditions through improved weight management, glycemic control, and lipid metabolism.